Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01363505 · ClinicalTrials.gov registry record
Bladder Pressure Predicting Renal Failure in Critically Ill Patients as Compared to Hemodynamic Parameters
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 16
- Enrollment target
NCT01363505 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 16 participants.
The verdict
NCT01363505 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Studies have shown that more than 30% of the overall acute decompensated heart failure (ADHF) patients develop renal dysfunction. Several studies have tried to find a correlation between hemodynamic Parameters (blood pressure , heart rate, central venous pressure CVP) and worsening of renal function in acute decompensated heart failure patients. Results showed that there were no correlation between baseline hemodynamics or change in hemodynamics and worsening of renal function. Another study showed that intra-abdominal pressure (IAP) measuring was a better corollary to renal failure status then measuring cardiovascular hemodynamics using pulmonary artery catheterization in ADHF patients.. An increased IAP was associated with worse renal function and that level of IAP far below abdominal compartment syndrome may adversely affect renal function in patients with ADHF.
Interventions
- DEVICE BARD® Intra-abdominal Pressure monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01363505
The ClinicalTrials.gov registry entry for NCT01363505 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BARD® Intra-abdominal Pressure monitor is the first listed.
NCT01363505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01363505 about?
NCT01363505 is a clinical study titled "Bladder Pressure Predicting Renal Failure in Critically Ill Patients as Compared to Hemodynamic Parameters". Studies have shown that more than 30% of the overall acute decompensated heart failure (ADHF) patients develop renal dysfunction. Several studies have tried to find a correlation between hemodynamic Parameters (blood pressure , heart rate, central venous pressure CVP) and worsening of renal functio...
What is the current status of trial NCT01363505?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2011-05. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01363505?
The interventions under investigation include: BARD® Intra-abdominal Pressure monitor (DEVICE).
Who is sponsoring clinical trial NCT01363505?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.